Share on LinkedInShare on LinkedIn

ARTICLE · 04 NOVEMBER 2020

Arbitration In The Pharma Sector: Amendment Of The LCAI Arbitration Rules

King, Stubb & Kasiva
King, Stubb & Kasiva
Contributor
King, Stubb & Kasiva

King, Stubb & Kasiva

King Stubb & Kasiva is few of the top corporate law firms in India with offices in Bengaluru,...

View firm profile
Explore more from King, Stubb & Kasiva

The use of international arbitration has augmented over the years to include a wide range of sectors. While the majority of financial disputes still transpire in court, some of them are submitted to arbitration.

IndiaLitigation, Mediation & Arbitration

The use of international arbitration has augmented over the years to include a wide range of sectors. While the majority of financial disputes still transpire in court, some of them are submitted to arbitration.

Life sciences giants often move out of their domestic markets in search of better growth opportunities in developed and emerging markets. Many of those developed and emerging markets already have their own pharma companies with significant annual revenues. For example, Mexico, Brazil, Russia, MEA REGION, India, Indonesia and South Africa all have pharmaceutical companies with revenue of USD 1 billion. The complex supply and distribution chains engaged by many pharma companies often extent multiple jurisdictions. Arbitration is well-suited for the settlement of disputes arising out of these types of complex, multi-jurisdictional agreements.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

https://ksandk.com/

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from